VRX.TO - Valeant Pharmaceuticals International, Inc.

Toronto - Toronto Delayed Price. Currency in CAD
Currency in CAD

Valuation Measures

Market Cap (intraday) 59.56B
Enterprise Value 336.02B
Trailing P/E 6.87
Forward P/E 17.71
PEG Ratio (5 yr expected) 1-0.43
Price/Sales (ttm)1.07
Price/Book (mrq)1.76
Enterprise Value/Revenue 34.02
Enterprise Value/EBITDA 610.05

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2016
Most Recent Quarter (mrq)Sep 30, 2017

Profitability

Profit Margin 15.35%
Operating Margin (ttm)9.35%

Management Effectiveness

Return on Assets (ttm)1.22%
Return on Equity (ttm)28.47%

Income Statement

Revenue (ttm)8.96B
Revenue Per Share (ttm)25.61
Quarterly Revenue Growth (yoy)-10.50%
Gross Profit (ttm)7.1B
EBITDA 3.58B
Net Income Avi to Common (ttm)1.38B
Diluted EPS (ttm)3.92
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)964M
Total Cash Per Share (mrq)2.77
Total Debt (mrq)27.14B
Total Debt/Equity (mrq)500.57
Current Ratio (mrq)1.26
Book Value Per Share (mrq)15.28

Cash Flow Statement

Operating Cash Flow (ttm)2.22B
Levered Free Cash Flow (ttm)3.31B

Trading Information

Stock Price History

Beta N/A
52-Week Change 338.07%
S&P500 52-Week Change 323.60%
52 Week High 330.56
52 Week Low 311.20
50-Day Moving Average 326.78
200-Day Moving Average 320.42

Share Statistics

Avg Vol (3 month) 32.35M
Avg Vol (10 day) 31.91M
Shares Outstanding 5348.58M
Float 306.56M
% Held by Insiders 1N/A
% Held by Institutions 1N/A
Shares Short 35.4M
Short Ratio 32.78
Short % of Float 31.65%
Shares Short (prior month) 35.88M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 4N/A
Dividend Date 3Dec 22, 2010
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 22/1
Last Split Date 3Oct 5, 2000